Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04702373 · ClinicalTrials.gov registry record · Phase 3
Training in Exercise Activities and Motion for Growth (TEAM 4 Growth) RCT
A Phase 3 study of Congenital Heart Disease, sponsored by Carelon Research.
- Active
- Registry status
- Phase 3
- Development phase
- 144
- Enrollment target
- 10
- Study locations
NCT04702373: Active Phase 3 study of Congenital Heart Disease, sponsored by Carelon Research.
NCT04702373 is a Phase 3 study of Congenital Heart Disease that is active but no longer recruiting, run by Carelon Research. The registered enrollment target is 144 participants, below the 472-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (69% lower). The trial reports 10 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04702373, a Phase 3 study of Congenital Heart Disease, is active but no longer recruiting, sponsored by Carelon Research.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 144 participants
- Enrollment target
- 10
- Study locations
Study Summary
This is a Phase III randomized controlled trial of a passive ROM exercise program that will be performed in infants with HLHS and other single right ventricle anomalies following the Norwood procedure at PHN and Auxiliary Centers.
Conditions Studied
Interventions
- OTHER passive range of motion exercise therapy
Study Locations (10)
Georgia
- Children's Healthcare of Atlanta / Emory University - Atlanta
Indiana
- Riley Children's Hospital of Indiana - Indianapolis
Massachusetts
- Boston Children's Hospital - Boston
Michigan
- University of Michigan - Ann Arbor
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
South Carolina
- Medical University of South Carolina - Charleston
Texas
- Texas Children's Hospital / Baylor - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2021-02-23 |
| Est. Completion | 2024-12-30 |
| Phase | Phase 3 |
What the registry record for NCT04702373 still lists
NCT04702373 is an interventional study that assigns participants to a tested intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap, below the 472-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (69% lower).
The record links to 1 condition, with Congenital Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which passive range of motion exercise therapy is the first listed.
NCT04702373 lists 10 locations in 10 states (Georgia, Indiana, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT04702373 about?
NCT04702373 is a clinical study titled "Training in Exercise Activities and Motion for Growth (TEAM 4 Growth) RCT". This is a Phase III randomized controlled trial of a passive ROM exercise program that will be performed in infants with HLHS and other single right ventricle anomalies following the Norwood procedure at PHN and Auxiliary Centers.
What is the current status of trial NCT04702373?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 144 participants. The study started on 2021-02-23. Estimated completion is 2024-12-30.
What conditions does trial NCT04702373 study?
This clinical trial studies the following conditions: Congenital Heart Disease.
What interventions are being tested in trial NCT04702373?
The interventions under investigation include: passive range of motion exercise therapy (OTHER).
Who is sponsoring clinical trial NCT04702373?
This trial is sponsored by Carelon Research, which has 50 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04702373 being conducted?
This trial has 10 study locations across Georgia, Indiana, Massachusetts, Michigan, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congenital Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04702373's enrollment target sits among peer trials
144 27th of 63 higher than 37 of 63 other Congenital Heart Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Congenital Heart Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Sacubitril-Valsartan on Cardiac Structure and Function
RECRUITING · Phase 3
-
Acute Normovolemic Hemodilution in Complex Cardiac Surgery
COMPLETED · Phase 3
-
Fontan Fitness Trial
RECRUITING · NA
-
Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
RECRUITING
-
A Study of Invasive Hemodynamic for MACHD Registry
RECRUITING
-
Remote Monitoring in Pregnant Women With Congenital Heart Disease Using Wrist Wearables
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01861106 · 144 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- NCT03482245 · 144 participants · NA
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- NCT03504683 · 144 participants · NA
MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes
- NCT03905603 · 144 participants · Early Phase 1
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI